4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling

Abstract Background Septic acute kidney injury (S-AKI) is the leading form of acute kidney failure among hospitalized patients, and the inflammatory response is involved in this process. 4-octyl itaconate (4-OI) is a multi-target itaconate derivative with potent anti-inflammatory action. However, it...

Full description

Bibliographic Details
Main Authors: Lujun Xu, Juan Cai, Chenrui Li, Ming Yang, Tongyue Duan, Qing Zhao, Yiyun Xi, Liya Sun, Liyu He, Chengyuan Tang, Lin Sun
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Molecular Medicine
Subjects:
Online Access:https://doi.org/10.1186/s10020-023-00631-8
_version_ 1797836449194704896
author Lujun Xu
Juan Cai
Chenrui Li
Ming Yang
Tongyue Duan
Qing Zhao
Yiyun Xi
Liya Sun
Liyu He
Chengyuan Tang
Lin Sun
author_facet Lujun Xu
Juan Cai
Chenrui Li
Ming Yang
Tongyue Duan
Qing Zhao
Yiyun Xi
Liya Sun
Liyu He
Chengyuan Tang
Lin Sun
author_sort Lujun Xu
collection DOAJ
description Abstract Background Septic acute kidney injury (S-AKI) is the leading form of acute kidney failure among hospitalized patients, and the inflammatory response is involved in this process. 4-octyl itaconate (4-OI) is a multi-target itaconate derivative with potent anti-inflammatory action. However, it remains elusive whether and how 4-OI contributes to the regulation of S-AKI. Methods We employed a lipopolysaccharide (LPS)-induced AKI murine model and explored the potential renoprotective effect of 4-OI in vivo. In vitro experiments, BUMPT cells, a murine renal tubular cell line, were conducted to examine the effects of 4-OI on inflammation, oxidative stress, and mitophagy. Moreover, STAT3 plasmid was transfected in BUMPT cells to investigate the role of STAT3 signaling in the 4-OI-administrated state. Results We demonstrate that 4-OI protects against S-AKI through suppressing inflammation and oxidative stress and enhancing mitophagy. 4-OI significantly reduced the levels of Scr, BUN, Ngal as well as the tubular injury in LPS-induced AKI mice. 4-OI restrained inflammation by reducing macrophage infiltration and suppressing the expression of IL-1β and NLRP3 in the septic kidney. 4-OI also reduced ROS levels, as well as cleaved caspase-3 and boosted antioxidants such as HO-1, and NQO1 in mice. In addition, the 4-OI treatment significantly promoted mitophagy. Mechanistically, 4-OI activated Nrf2 signaling and suppressed phosphorylated STAT3 in vivo and vitro. Molecular docking revealed the binding affinity of 4-OI towards STAT3. ML385, a specific Nrf2 inhibitor, partially repressed the anti-inflammatory and anti-oxidative effects of 4-OI and partially restricted the mitophagy induced by 4-OI in vivo and in  vitro. Transfected with STAT3 plasmid partially suppressed mitophagy and the anti-inflammatory effect provoked by 4-OI in vitro. Conclusion These data suggest that 4-OI ameliorates LPS-induced AKI by suppressing inflammation and oxidative stress and enhancing mitophagy through the overactivation of the Nrf2 signaling pathway, and inactivation of STAT3. Our study identifies 4-OI as a promising pharmacologic for S-AKI.
first_indexed 2024-04-09T15:09:04Z
format Article
id doaj.art-e90c99c0434f4d3686e01b72e9770771
institution Directory Open Access Journal
issn 1528-3658
language English
last_indexed 2024-04-09T15:09:04Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj.art-e90c99c0434f4d3686e01b72e97707712023-04-30T11:19:04ZengBMCMolecular Medicine1528-36582023-04-0129111510.1186/s10020-023-00631-84-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signalingLujun Xu0Juan Cai1Chenrui Li2Ming Yang3Tongyue Duan4Qing Zhao5Yiyun Xi6Liya Sun7Liyu He8Chengyuan Tang9Lin Sun10Department of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityDepartment of Nephrology, Key Laboratory of Kidney Disease and Blood Purification, The Second Xiangya Hospital of Central South UniversityAbstract Background Septic acute kidney injury (S-AKI) is the leading form of acute kidney failure among hospitalized patients, and the inflammatory response is involved in this process. 4-octyl itaconate (4-OI) is a multi-target itaconate derivative with potent anti-inflammatory action. However, it remains elusive whether and how 4-OI contributes to the regulation of S-AKI. Methods We employed a lipopolysaccharide (LPS)-induced AKI murine model and explored the potential renoprotective effect of 4-OI in vivo. In vitro experiments, BUMPT cells, a murine renal tubular cell line, were conducted to examine the effects of 4-OI on inflammation, oxidative stress, and mitophagy. Moreover, STAT3 plasmid was transfected in BUMPT cells to investigate the role of STAT3 signaling in the 4-OI-administrated state. Results We demonstrate that 4-OI protects against S-AKI through suppressing inflammation and oxidative stress and enhancing mitophagy. 4-OI significantly reduced the levels of Scr, BUN, Ngal as well as the tubular injury in LPS-induced AKI mice. 4-OI restrained inflammation by reducing macrophage infiltration and suppressing the expression of IL-1β and NLRP3 in the septic kidney. 4-OI also reduced ROS levels, as well as cleaved caspase-3 and boosted antioxidants such as HO-1, and NQO1 in mice. In addition, the 4-OI treatment significantly promoted mitophagy. Mechanistically, 4-OI activated Nrf2 signaling and suppressed phosphorylated STAT3 in vivo and vitro. Molecular docking revealed the binding affinity of 4-OI towards STAT3. ML385, a specific Nrf2 inhibitor, partially repressed the anti-inflammatory and anti-oxidative effects of 4-OI and partially restricted the mitophagy induced by 4-OI in vivo and in  vitro. Transfected with STAT3 plasmid partially suppressed mitophagy and the anti-inflammatory effect provoked by 4-OI in vitro. Conclusion These data suggest that 4-OI ameliorates LPS-induced AKI by suppressing inflammation and oxidative stress and enhancing mitophagy through the overactivation of the Nrf2 signaling pathway, and inactivation of STAT3. Our study identifies 4-OI as a promising pharmacologic for S-AKI.https://doi.org/10.1186/s10020-023-00631-8sepsisAcute kidney injury4-octyl itaconateOxidative stressInflammationMitophagy
spellingShingle Lujun Xu
Juan Cai
Chenrui Li
Ming Yang
Tongyue Duan
Qing Zhao
Yiyun Xi
Liya Sun
Liyu He
Chengyuan Tang
Lin Sun
4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
Molecular Medicine
sepsis
Acute kidney injury
4-octyl itaconate
Oxidative stress
Inflammation
Mitophagy
title 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
title_full 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
title_fullStr 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
title_full_unstemmed 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
title_short 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling
title_sort 4 octyl itaconate attenuates lps induced acute kidney injury by activating nrf2 and inhibiting stat3 signaling
topic sepsis
Acute kidney injury
4-octyl itaconate
Oxidative stress
Inflammation
Mitophagy
url https://doi.org/10.1186/s10020-023-00631-8
work_keys_str_mv AT lujunxu 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT juancai 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT chenruili 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT mingyang 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT tongyueduan 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT qingzhao 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT yiyunxi 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT liyasun 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT liyuhe 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT chengyuantang 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling
AT linsun 4octylitaconateattenuateslpsinducedacutekidneyinjurybyactivatingnrf2andinhibitingstat3signaling